Work

Stem cell-derived dopamine cell therapies for Parkinson’s disease: what have the first trials shown?

Year: 2025

Type: article

Abstract: This scientific commentary refers to ‘Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease’ by Sawamoto et al. (https://doi.org/10.1038/s41586-025-08700-0) and ‘Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease’ by Tabar et al. (https://doi.org/10.1038/s41586-025-08845-y).

Source: Brain

DOI: 10.1093/brain/awaf322

Authors: Roger A Barker, Malin Parmar

Institutions: Wellcome/MRC Cambridge Stem Cell Institute, University of Cambridge, Lund University

Language: English

Topic: Pluripotent Stem Cells Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4413960432